关注
Michael Boffa
Michael Boffa
Associate Professor of Biochemistry, University of Western Ontario
在 uwo.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor
W Wang, MB Boffa, L Bajzar, JB Walker, ME Nesheim
Journal of Biological Chemistry 273 (42), 27176-27181, 1998
5291998
Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis
M Nesheim, W Wang, M Boffa, M Nagashima, J Morser, L Bajzar
Thrombosis and haemostasis 78 (07), 386-391, 1997
3621997
Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation
LO Mosnier, PAK von dem Borne, JCM Meijers, BN Bouma
Thrombosis and haemostasis 80 (11), 829-835, 1998
2971998
Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation …
MB Boffa, W Wang, L Bajzar, ME Nesheim
Journal of Biological Chemistry 273 (4), 2127-2135, 1998
2601998
Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
MB Boffa, ML Koschinsky
Journal of lipid research 57 (5), 745-757, 2016
2582016
Lipoprotein (a) levels and the risk of myocardial infarction among 7 ethnic groups
G Paré, A Çaku, M McQueen, SS Anand, E Enas, R Clarke, MB Boffa, ...
Circulation 139 (12), 1472-1482, 2019
2562019
Lipoprotein (a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor
R Romagnuolo, CA Scipione, MB Boffa, SM Marcovina, NG Seidah, ...
Journal of Biological Chemistry 290 (18), 11649-11662, 2015
2332015
Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme
M Schneider, M Boffa, R Stewart, M Rahman, M Koschinsky, M Nesheim
Journal of Biological Chemistry 277 (2), 1021-1030, 2002
2332002
Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a) 1
G Leibundgut, C Scipione, H Yin, M Schneider, MB Boffa, S Green, ...
Journal of lipid research 54 (10), 2815-2830, 2013
2292013
Lipoprotein (a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models
MB Boffa, SM Marcovina, ML Koschinsky
Clinical biochemistry 37 (5), 333-343, 2004
2182004
Oxidized phospholipids as a unifying theory for lipoprotein (a) and cardiovascular disease
MB Boffa, ML Koschinsky
Nature Reviews Cardiology 16 (5), 305-318, 2019
1972019
Inhibition of plasminogen activation by lipoprotein (a): critical domains in apolipoprotein (a) and mechanism of inhibition on fibrin and degraded fibrin surfaces
MA Hancock, MB Boffa, SM Marcovina, ME Nesheim, ML Koschinsky
Journal of Biological Chemistry 278 (26), 23260-23269, 2003
1852003
A zebrafish retinoic acid receptor expressed in the regenerating caudal fin
JA White, MB Boffa, B Jones, M Petkovich
Development 120 (7), 1861-1872, 1994
1711994
Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor
MB Boffa, R Bell, WK Stevens, ME Nesheim
Journal of Biological Chemistry 275 (17), 12868-12878, 2000
1702000
Subclinical vitamin K deficiency in hemodialysis patients
RM Pilkey, AR Morton, MB Boffa, C Noordhof, AG Day, Y Su, LM Miller, ...
American journal of kidney diseases 49 (3), 432-439, 2007
1642007
A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated …
GJ Brouwers, HL Vos, FWG Leebeek, S Bulk, M Schneider, M Boffa, ...
Blood, The Journal of the American Society of Hematology 98 (6), 1992-1993, 2001
1632001
Lipoprotein (a): more interesting than ever after 50 years
JB Dubé, MB Boffa, RA Hegele, ML Koschinsky
Current opinion in lipidology 23 (2), 133-140, 2012
1522012
Lipoprotein (a): a unique risk factor for cardiovascular disease
E Anuurad, MB Boffa, ML Koschinsky, L Berglund
Clinics in laboratory medicine 26 (4), 751-772, 2006
1462006
Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B)
MB Boffa, TS Reid, E Joo, ME Nesheim, ML Koschinsky
Biochemistry 38 (20), 6547-6558, 1999
1431999
Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and …
MB Boffa, ML Koschinsky
Clinical biochemistry 40 (7), 431-442, 2007
1192007
系统目前无法执行此操作,请稍后再试。
文章 1–20